author-photo

Isabelle Girault

French Institute of Health and Medical Research

27

Papers

911

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Response assessment to anti-CTLA4 or/and anti-PD1 immunotherapy in mucosal melanomas.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Identification de TBX3 comme nouveau régulateur de l’expression de PDL1 dans le mélanome

2018 Annales De Dermatologie Et De Venereologie
Show All
- Source
- Cite
- Save
Citations (0)
Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

2018 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (89)
A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab in patients (pts) with metastatic melanoma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab (Ipi) in patients (pts) with metastatic melanoma

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (30)
Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines

2016 Cell Cycle
Show All
- Source
- Cite
- Save
Citations (9)
Abstract A23: eIF4F is a key and targetable convergence nexus of multiple mechanisms of resistance to anti-BRAF and anti-MEK cancer therapies

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 934: BRAF inhibitors induce skin and extra-cutaneous tumors via paradoxical activation of the MAPK pathway: Molecular study of 66 tumors and visualization of BRAF/CRAF protein dimers

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

2014 Nature
Show All
- Source
- Cite
- Save
Citations (234)